| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
3,674
|
3,788
|
3,518
|
2,924
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
3,674
|
3,788
|
3,518
|
2,924
| |
|
Operating Expenses |
|
Research Development | 7,079 | 8,930 | 12,050 | 9,861 |
|
Selling General and Administrative | 2,042 | 1,805 | 2,201 | 2,308 |
|
Non Recurring |
-
| (18) | (17) | 28 |
|
Others | 2,181 | 972 | 974 | 973 |
|
|
|
Total Operating Expenses |
-
| 11,689 | 15,208 | 13,170 | | | |
Operating Income or Loss
|
(7,628)
|
(7,901)
|
(11,690)
|
(10,246)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 21 | 101 | 48 | 44 |
|
Earnings Before Interest And Taxes | (7,607) | (7,800) | (11,642) | (10,202) |
|
Interest Expense | 440 | 487 | 532 | 563 |
|
Income Before Tax | (8,047) | (8,287) | (12,174) | (10,765) |
|
Income Tax Expense |
-
|
-
|
-
| (441) |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (8,047) | (8,287) | (12,174) | (10,324) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(8,047)
|
(8,287)
|
(12,174)
|
(10,324)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(8,047)
|
(8,287)
|
(12,174)
|
(10,324)
|
|
0.02(3.47%) 11:04AM EDT - Nasdaq Real Time Price